Patents by Inventor James M. Manning

James M. Manning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9000334
    Abstract: A Bleve (Boiling Liquid Expanding Vapor Explosion) reaction wherein fuel is pumped from a fuel line and is fed through a solenoid valve to a BLEVE reaction chamber. The BLEVE reaction takes place in the bleve chamber, during which a bleve is released and supplied via the bleve outlet nozzle. A thermal housing with embedded electrical resistive wire, is a method and installation for generating sufficient heat causing a bleve. The fuel is heated by the electrical resistive wire as it is moved into the bleve-reaction chamber. As bleved fuel is introduced into the combustion chamber, the latent heat causes the bleve to auto-ignite upon contact with the oxygen producing a blue flame. The cycle of the process is controlled by means of a regulating control. The method described is particularly suited for a bleved fuel valve nozzled burner.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: April 7, 2015
    Inventors: William H. Manning, James M. Manning, Glenn M Pearson
  • Patent number: 4349352
    Abstract: The invention is a process for a rapid and precise colorimetric method for determination of the total glucosylated blood proteins. The method is especially adapted and useful as a clinical, diagnostic aid for identification, management and treatment for diabetics. The method essentially comprises use of phenylhydrazine derivatives as reagents to determine the extent of glucosylation of hemoglobin and other proteins in the blood samples tested. The adduct of the aldehyde sugar (glucose) and the hemoglobin possesses the ketoamine structure. This structure is readily detected colorimetrically after treatment with a phenylhydrazine to give the corresponding phenylhydrazone. Phenylhydrazine and 2,4-dinitrophenylhydrazine are preferred reagents for the diagnostic process.
    Type: Grant
    Filed: August 14, 1980
    Date of Patent: September 14, 1982
    Assignee: Rockefeller University
    Inventors: James M. Manning, Seetharama A. Acharya